An FDA committee votes to roll out a new COVID vaccination strategy
(By Scott Hensley for NPR) A committee of advisers to the Food and Drug Administration voted unanimously on a proposal
Read moreFDA
A dangerous loophole for drug ads needs to be closed
(By John P. Moore and G. Caleb Alexander for STAT) A loophole in prescription drug regulation exposes American consumers to
Read moreFDA considers major shift in COVID vaccine strategy
(By Rob Stein for NPR) The Food and Drug Administration is considering a major shift in the nation’s COVID-19 vaccine
Read moreFDA approves Alzheimer’s drug that appears to modestly slow disease
(By Jon Hamilton for NPR) The Food and Drug Administration has approved a drug that may help people in the
Read moreFDA’s vaccines chief sees possibility of more Covid boosters — sooner than he’d like
(By Helen Branswell for STAT) Peter Marks, who leads the Food and Drug Administration’s vaccines operation, is still losing sleep
Read moreSay What? Hearing Aids Available Over-the-Counter for as Low as $199, and Without a Prescription
(By Phil Galewitz for Kaiser Health News) Starting Monday, consumers will be able to buy hearing aids directly off store
Read moreFDA approves ALS drug from Amylyx, giving patients a much-needed treatment option
(By Damian Garde for STAT) The Food and Drug Administration approved a new medicine for ALS from Amylyx Pharmaceuticals on
Read morePharma-Funded FDA Gets Drugs Out Faster, But Some Work Only ‘Marginally’ and Most Are Pricey
(By Arthur Allen for Kaiser Health News) Dr. Steven-Huy Han, a UCLA liver specialist, has prescribed Ocaliva to a handful
Read moreFDA seems poised to approve a new drug for ALS, but does it work?
(By Jon Hamilton for NPR) The Food and Drug Administration is likely to approve a controversial new drug for ALS
Read moreOmicron boosters: Do I need one, and if so, when?
By Allison Aubrey for NPR /Heard on Morning Edition September 5, 2022 The Centers for Disease Control and Prevention is recommending
Read more